EyePoint (EYPT) Non-Current Deffered Revenue (2011 - 2024)

EyePoint (EYPT) reported Non-Current Deffered Revenue of $10.9 million for Q4 2024, down 47.55% on a YoY basis from $20.7 million in Q1 2024, and down 3.39% sequentially from $11.2 million in Q3 2024.

EyePoint (EYPT) Non-Current Deffered Revenue (2011 - 2024) Analysis & Trends

EyePoint (EYPT) has 12 years of Non-Current Deffered Revenue data on file, last reported at $10.9 million in Q4 2024.

  • For the quarter ending Q4 2024, Non-Current Deffered Revenue fell 47.55% year-over-year to $10.9 million; the trailing twelve-month figure through Dec 2024 stood at $10.9 million (down 47.55% YoY), and the FY2024 full-year result was $10.9 million, down 47.55% from the prior year.
  • Non-Current Deffered Revenue retreated to $10.9 million in Q4 2024, from $11.2 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $44.0 million in Q2 2023 to a low of $10.9 million in Q4 2024.
  • A 5-year average of $16.9 million and a median of $14.3 million in 2022 frame the typical range for Non-Current Deffered Revenue.
  • Across the five-year window, Non-Current Deffered Revenue soared 212.87% in 2023 and tumbled 73.47% in 2024, its largest moves.
  • Tracing EYPT's Non-Current Deffered Revenue over 5 years: stood at $15.6 million in 2020, then slipped by 6.76% to $14.6 million in 2021, then retreated by 6.89% to $13.6 million in 2022, then soared by 52.63% to $20.7 million in 2023, then slumped by 47.55% to $10.9 million in 2024.
  • Business Quant data shows EYPT's Non-Current Deffered Revenue at $10.9 million in Q4 2024, $11.2 million in Q3 2024, and $11.7 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2024 10.85 Mn
Sep 30, 2024 11.23 Mn
Jun 30, 2024 11.68 Mn
Mar 31, 2024 12.11 Mn
Dec 31, 2023 20.69 Mn
Sep 30, 2023 32.34 Mn
Jun 30, 2023 44.02 Mn
Mar 31, 2023 13.27 Mn
Dec 31, 2022 13.56 Mn
Sep 30, 2022 13.80 Mn
Jun 30, 2022 14.07 Mn
Mar 31, 2022 14.30 Mn
Dec 31, 2021 14.56 Mn
Sep 30, 2021 14.79 Mn
Jun 30, 2021 15.13 Mn
Mar 31, 2021 15.35 Mn
Dec 31, 2020 15.62 Mn
Dec 31, 2017 42,000.00
Sep 30, 2017 47,000.00
Jun 30, 2017 51,000.00